RE: VACCINE10 Nov 2020 18:24
there's a contract right under QFI's nose in Utah. I posted that it concerned me that the bod seemed pleased to the point of complacency that they had bergen funding until Q1 2021, which is now almost upon us. In the bod's defence I think they've been dealt a hard hand to play and they have made other progress on the projects that are most close to commercialisation. Nevertheless, winter is coming. Unless they strike a deal with Greenfield to boost revenue, then it is likely they will have to do another dilutive placing in late Q1 to keep the lights on. From my reading of the RNS at the time of the first Bergen tranche, there were conditions applied to agreeing to a second tranche, conditions that the company may not have met.
For new posters, Bergen are investors, who make finance available to companys who cannot easily raise money in more conventional ways. These are usually in the form of convertible loans, where Bergen make a cash "loan" to QFI and instead of repaying Bergen in cash, they are repaid in newly issued shares (the implied price of which would be at significant discount to the market price ), sometimes they are also granted options too with exercise prices at considerable discounts to the market price.
There are potential drawbacks to existing shareholders. :- risk of pump and dump, dilution
As I've said before, rather than seeking to find prospects that may become commercial projects in years to come, it is time to close the deal with Asphalt Ridge Utah. If that can't be closed before seeking further finance, then I can't see a clear way forward that would hold any attraction to existing shareholders.
The POSP is about to restart with its upgrade within days.